Evidence map›Paper›PMID 39203027›Full record

ArticleMolecules (Basel, Switzerland)2024

Effect of

Charbel Chahla, Mohamad Rima, Charbel Mouawad, Rabih Roufayel, Hervé Kovacic, Dany El Obeid, Jean-Marc Sabatier, José Luis, Ziad Fajloun, Bilal El-Waly

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Therapeutic Bioactivity Exerted by theMolecules (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charbel ChahlaInst Neurophysiopathol (INP), CNRS, Aix-Marseille Université, 13385 Marseille, France.
Mohamad RimaDepartment of Natural Sciences, Lebanese American University, Byblos P.O. Box 36, Lebanon.ORCID 0000-0002-0335-9882
Charbel MouawadLaboratoire d'Histologie Embryologie Biologie de la Reproduction CECOS, Assistance Publique-Hôpitaux Universitaires Paris Centre, CHU Cochin, 75014 Paris, France.
Rabih RoufayelCollege of Engineering and Technology, American University of the Middle East, Egaila 54200, Kuwait.ORCID 0000-0002-4595-1104
Hervé KovacicInst Neurophysiopathol (INP), CNRS, Aix-Marseille Université, 13385 Marseille, France.ORCID 0000-0001-6509-4210
Dany El ObeidFaculty of Agriculture & Veterinary Sciences, Lebanese University, Dekwaneh, Beirut 1100, Lebanon.ORCID 0000-0002-1967-1918
Jean-Marc SabatierInst Neurophysiopathol (INP), CNRS, Aix-Marseille Université, 13385 Marseille, France.ORCID 0000-0002-9040-5647
José LuisInst Neurophysiopathol (INP), CNRS, Aix-Marseille Université, 13385 Marseille, France.ORCID 0000-0001-7419-6016
Ziad FajlounLaboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and Its Applications, Department of Cell Culture, EDST, Lebanese University, Tripoli 1300, Lebanon.ORCID 0000-0002-6502-3110
Bilal El-WalyLaboratory of Applied Biotechnology (LBA3B), Azm Center for Research in Biotechnology and Its Applications, Department of Cell Culture, EDST, Lebanese University, Tripoli 1300, Lebanon.ORCID 0000-0003-2991-3754

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma multiforme (GBM) is a highly aggressive and fatal primary brain tumor. The resistance of GBM to conventional treatments is attributed to factors such as the blood-brain barrier, tumor heterogeneity, and treatment-resistant stem cells. Current therapeutic efforts show limited survival benefits, emphasizing the urgent need for novel treatments. In this context, natural anti-cancer extracts and especially animal venoms have garnered attention for their potential therapeutic benefits. Bee venom in general and that of the Middle Eastern bee,

Indexed as

Antineoplastic AgentsApoptosisBee VenomsGlioblastomaAnimalsBeesBrain NeoplasmsCell Line, TumorCell ProliferationCell SurvivalHumansMiceXenograft Model Antitumor AssaysAntineoplastic AgentsBee Venomsanimal venomanti-cancerApis melliferaApis mellifera syriacacell viabilitycytotoxicityglioblastomain vitroin vivotherapeutic efficacy

Identifiers

PMID39203027
PMCPMC11357583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.